🚀 VC round data is live in beta, check it out!
MGI Tech Valuation Multiples
Discover revenue and EBITDA valuation multiples for MGI Tech and similar public comparables like Integer Holdings, Ambu, Haemonetics, Carl Zeiss Meditec and more.
MGI Tech Overview
About MGI Tech
MGI Tech Co Ltd is a producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. It provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare, and other relevant industries.
Founded
2016
HQ
Employees
N/A
Website
Financials (LTM)
EV
$3B
MGI Tech Financials
MGI Tech reported last 12-month revenue of $433M and EBITDA of $39M.
In the same LTM period, MGI Tech generated $228M in gross profit, $39M in EBITDA, and had net loss of ($27M).
Revenue (LTM)
MGI Tech P&L
In the most recent fiscal year, MGI Tech reported revenue of $442M and EBITDA of ($13M).
MGI Tech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $433M | XXX | $442M | XXX | XXX | XXX |
| Gross Profit | $228M | XXX | $245M | XXX | XXX | XXX |
| Gross Margin | 53% | XXX | 56% | XXX | XXX | XXX |
| EBITDA | $39M | XXX | ($13M) | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | (3%) | XXX | XXX | XXX |
| EBIT Margin | (7%) | XXX | (13%) | XXX | XXX | XXX |
| Net Profit | ($27M) | XXX | ($82M) | XXX | XXX | XXX |
| Net Margin | (6%) | XXX | (19%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MGI Tech Stock Performance
MGI Tech has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
MGI Tech's stock price is $7.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 0.0% | XXX | XXX | XXX | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMGI Tech Valuation Multiples
MGI Tech trades at 6.3x EV/Revenue multiple, and 69.6x EV/EBITDA.
EV / Revenue (LTM)
MGI Tech Financial Valuation Multiples
As of April 19, 2026, MGI Tech has market cap of $3B and EV of $3B.
Equity research analysts estimate MGI Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MGI Tech has a P/E ratio of (113.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 6.3x | XXX | 6.2x | XXX | XXX | XXX |
| EV/EBITDA | 69.6x | XXX | (202.1x) | XXX | XXX | XXX |
| EV/EBIT | (90.6x) | XXX | (49.2x) | XXX | XXX | XXX |
| EV/Gross Profit | 11.9x | XXX | 11.1x | XXX | XXX | XXX |
| P/E | (113.1x) | XXX | (36.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (16.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MGI Tech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MGI Tech Margins & Growth Rates
MGI Tech's revenue in the last 12 month grew by 16%.
MGI Tech's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MGI Tech's rule of X is 44% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
MGI Tech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | (6%) | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Growth | 76% | XXX | (314%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 44% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 24% | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 18% | XXX | 19% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 23% | XXX | 25% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 68% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MGI Tech Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MGI Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| Integer Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ambu | XXX | XXX | XXX | XXX | XXX | XXX |
| Haemonetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Carl Zeiss Meditec | XXX | XXX | XXX | XXX | XXX | XXX |
| Autobio Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MGI Tech M&A Activity
MGI Tech acquired XXX companies to date.
Last acquisition by MGI Tech was on XXXXXXXX, XXXXX. MGI Tech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MGI Tech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMGI Tech Investment Activity
MGI Tech invested in XXX companies to date.
MGI Tech made its latest investment on XXXXXXXX, XXXXX. MGI Tech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MGI Tech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MGI Tech
| When was MGI Tech founded? | MGI Tech was founded in 2016. |
| Where is MGI Tech headquartered? | MGI Tech is headquartered in China. |
| Is MGI Tech publicly listed? | Yes, MGI Tech is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of MGI Tech? | MGI Tech trades under 688114 ticker. |
| When did MGI Tech go public? | MGI Tech went public in 2022. |
| Who are competitors of MGI Tech? | MGI Tech main competitors are Integer Holdings, Ambu, Haemonetics, Carl Zeiss Meditec. |
| What is the current market cap of MGI Tech? | MGI Tech's current market cap is $3B. |
| What is the current revenue of MGI Tech? | MGI Tech's last 12 months revenue is $433M. |
| What is the current revenue growth of MGI Tech? | MGI Tech revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of MGI Tech? | Current revenue multiple of MGI Tech is 6.3x. |
| Is MGI Tech profitable? | Yes, MGI Tech is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MGI Tech? | MGI Tech's last 12 months EBITDA is $39M. |
| What is MGI Tech's EBITDA margin? | MGI Tech's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of MGI Tech? | Current EBITDA multiple of MGI Tech is 69.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.